Cargando…
Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy
BACKGROUND: The Mre11-Rad50-Nbs1 (MRN) complex is well known for its crucial role in initiating DNA double strand breaks (DSBs) repair pathways to resistant irradiation (IR) injury and thus facilitating radioresistance which severely reduces radiocurability of nasopharyngeal cancer (NPC). Targeting...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782334/ https://www.ncbi.nlm.nih.gov/pubmed/26951044 http://dx.doi.org/10.1186/s12885-016-2190-8 |
_version_ | 1782419932292579328 |
---|---|
author | Chang, Lihong Huang, Jiancong Wang, Kai Li, Jingjia Yan, Ruicheng Zhu, Ling Ye, Jin Wu, Xifu Zhuang, Shimin Li, Daqing Zhang, Gehua |
author_facet | Chang, Lihong Huang, Jiancong Wang, Kai Li, Jingjia Yan, Ruicheng Zhu, Ling Ye, Jin Wu, Xifu Zhuang, Shimin Li, Daqing Zhang, Gehua |
author_sort | Chang, Lihong |
collection | PubMed |
description | BACKGROUND: The Mre11-Rad50-Nbs1 (MRN) complex is well known for its crucial role in initiating DNA double strand breaks (DSBs) repair pathways to resistant irradiation (IR) injury and thus facilitating radioresistance which severely reduces radiocurability of nasopharyngeal cancer (NPC). Targeting native cellular MRN function would sensitize NPC cells to IR. METHODS: A recombinant adenovirus containing a mutant Rad50 gene (Ad-RAD50) expressing Rad50 zinc hook domain but lacking the ATPase domain and the Mre11 interaction domain was constructed to disrupt native cellular MRN functions. The effects of Ad-RAD50 on the MRN functions were assessed in NPC cells lines using western blot, co-immunoprecipitation and confocal microscopy analyses. The increased radiosensitivity of transient Ad-RAD50 to IR was examined in NPC cells, including MTT assay, colony formation. The molecular mechanisms of radiosensitization were confirmed by neutral comet assay and western bolts. Nude mice subcutaneous injection, tumor growth curve and TUNEL assay were used to evaluate tumor regression and apoptosis in vivo. RESULTS: Rad50 is remarkably upregulated in NPC cells after IR, implying the critical role of Rad50 in MRN functions. The transient expression of this mutant Rad50 decreased the levels of native cellular Rad50, Mre11 and Nbs1, weakened the interactions among these proteins, abrogated the G2/M arrest induced by DSBs and reduced the DNA repair ability in NPC cells. A combination of IR and mutant RAD50 therapy produced significant tumor cytotoxicity in vitro, with a corresponding increase in DNA damage, prevented proliferation and cell viability. Furthermore, Ad-RAD50 sensitized NPC cells to IR by causing dramatic tumor regression and inducing apoptosis in vivo. CONCLUSION: Our findings define a novel therapeutic approach to NPC radiosensitization via targeted native cellular Rad50 disruption. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2190-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4782334 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47823342016-03-09 Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy Chang, Lihong Huang, Jiancong Wang, Kai Li, Jingjia Yan, Ruicheng Zhu, Ling Ye, Jin Wu, Xifu Zhuang, Shimin Li, Daqing Zhang, Gehua BMC Cancer Research Article BACKGROUND: The Mre11-Rad50-Nbs1 (MRN) complex is well known for its crucial role in initiating DNA double strand breaks (DSBs) repair pathways to resistant irradiation (IR) injury and thus facilitating radioresistance which severely reduces radiocurability of nasopharyngeal cancer (NPC). Targeting native cellular MRN function would sensitize NPC cells to IR. METHODS: A recombinant adenovirus containing a mutant Rad50 gene (Ad-RAD50) expressing Rad50 zinc hook domain but lacking the ATPase domain and the Mre11 interaction domain was constructed to disrupt native cellular MRN functions. The effects of Ad-RAD50 on the MRN functions were assessed in NPC cells lines using western blot, co-immunoprecipitation and confocal microscopy analyses. The increased radiosensitivity of transient Ad-RAD50 to IR was examined in NPC cells, including MTT assay, colony formation. The molecular mechanisms of radiosensitization were confirmed by neutral comet assay and western bolts. Nude mice subcutaneous injection, tumor growth curve and TUNEL assay were used to evaluate tumor regression and apoptosis in vivo. RESULTS: Rad50 is remarkably upregulated in NPC cells after IR, implying the critical role of Rad50 in MRN functions. The transient expression of this mutant Rad50 decreased the levels of native cellular Rad50, Mre11 and Nbs1, weakened the interactions among these proteins, abrogated the G2/M arrest induced by DSBs and reduced the DNA repair ability in NPC cells. A combination of IR and mutant RAD50 therapy produced significant tumor cytotoxicity in vitro, with a corresponding increase in DNA damage, prevented proliferation and cell viability. Furthermore, Ad-RAD50 sensitized NPC cells to IR by causing dramatic tumor regression and inducing apoptosis in vivo. CONCLUSION: Our findings define a novel therapeutic approach to NPC radiosensitization via targeted native cellular Rad50 disruption. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2190-8) contains supplementary material, which is available to authorized users. BioMed Central 2016-03-07 /pmc/articles/PMC4782334/ /pubmed/26951044 http://dx.doi.org/10.1186/s12885-016-2190-8 Text en © Chang et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Chang, Lihong Huang, Jiancong Wang, Kai Li, Jingjia Yan, Ruicheng Zhu, Ling Ye, Jin Wu, Xifu Zhuang, Shimin Li, Daqing Zhang, Gehua Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy |
title | Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy |
title_full | Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy |
title_fullStr | Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy |
title_full_unstemmed | Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy |
title_short | Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy |
title_sort | targeting rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782334/ https://www.ncbi.nlm.nih.gov/pubmed/26951044 http://dx.doi.org/10.1186/s12885-016-2190-8 |
work_keys_str_mv | AT changlihong targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy AT huangjiancong targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy AT wangkai targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy AT lijingjia targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy AT yanruicheng targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy AT zhuling targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy AT yejin targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy AT wuxifu targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy AT zhuangshimin targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy AT lidaqing targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy AT zhanggehua targetingrad50sensitizeshumannasopharyngealcarcinomacellstoradiotherapy |